🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, alleging the corporations concealed safety concerns that the pain reliever created to children's brain development.

The lawsuit comes four weeks after President Donald Trump advocated an unverified association between using Tylenol - also known as paracetamol - throughout gestation and autism spectrum disorder in young ones.

The attorney general is suing J&J, which once produced the drug, the only pain reliever recommended for expectant mothers, and Kenvue, which now manufacturers it.

In a statement, he claimed they "deceived the public by gaining financially from pain and pushing pills ignoring the dangers."

The manufacturer says there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to increase profits," the attorney general, a Republican, said.

The manufacturer commented that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its website, Kenvue also said it had "regularly reviewed the pertinent research and there is insufficient valid information that demonstrates a established connection between using acetaminophen and autism."

Associations representing doctors and health professionals concur.

The leading OB-GYN organization has declared paracetamol - the primary component in acetaminophen - is a restricted selection for expectant mothers to address pain and fever, which can present serious health risks if left untreated.

"In more than two decades of research on the utilization of paracetamol in gestation, not a single reputable study has definitively established that the use of acetaminophen in any period of pregnancy leads to neurological conditions in children," the group said.

The lawsuit mentions recent announcements from the Trump administration in arguing the medication is potentially dangerous.

Recently, the former president raised alarms from medical authorities when he told pregnant women to "fight like hell" not to take acetaminophen when unwell.

The FDA then issued a notice that physicians should consider limiting the consumption of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Kennedy, who manages the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would establish the source of autism spectrum disorder in a matter of months.

But experts warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of genetic and environmental factors - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and impairment that impacts how people encounter and relate to the surroundings, and is diagnosed using physician assessments.

In his legal document, Paxton - aligned with the former president who is campaigning for US Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the science" around acetaminophen and autism.

The lawsuit aims to force the corporations "eliminate any marketing or advertising" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit echoes the concerns of a collection of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of acetaminophen in two years ago.

The court rejected the legal action, stating studies from the parents' expert witnesses was inconclusive.